Dentsply Sirona Inc (STU:DY2)
€ 18.4 -0.335 (-1.79%) Market Cap: 3.67 Bil Enterprise Value: 5.60 Bil PE Ratio: 0 PB Ratio: 1.55 GF Score: 61/100

Dentsply Sirona Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 03:45PM GMT
Release Date Price: €37.98 (+2.06%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. Welcome to the continuation of day 2 of the Barclays Global Healthcare Conference. I'm Steven Valiquette, the health care services analyst here at Barclays. And our next session this morning will feature Dentsply Sirona. Pleased to have from the company Don Casey, CEO; and also John Sweeney from Investor Relations as well. So thanks for your flexibility around the change in our conference venue, and welcome.

Questions & Answers

Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

And so let's just start off talking about the 2020 outlook. I mean the company just provided 2020 EPS guidance that would have been above The Street consensus at the midpoint if not for the coronavirus impact. And obviously, we'll get to some questions on coronavirus a little bit later, but let's first talk about the drivers of growth for this year. And I'm curious whether you think more of your bottom line growth in 2020 will come from new product sales or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot